Fax: +7-812-596-8947
Carcinogenesis
Effect of exposure to light-at-night on life span and spontaneous carcinogenesis in female CBA mice
Article first published online: 4 MAY 2004
DOI: 10.1002/ijc.20298
Copyright © 2004 Wiley-Liss, Inc.
Additional Information
How to Cite
Anisimov, V. N., Baturin, D. A., Popovich, I. G., Zabezhinski, M. A., Manton, K. G., Semenchenko, A. V. and Yashin, A. I. (2004), Effect of exposure to light-at-night on life span and spontaneous carcinogenesis in female CBA mice. Int. J. Cancer, 111: 475–479. doi: 10.1002/ijc.20298
Publication History
- Issue published online: 1 JUL 2004
- Article first published online: 4 MAY 2004
- Manuscript Accepted: 5 FEB 2004
- Manuscript Revised: 29 DEC 2003
- Manuscript Received: 14 NOV 2003
Funded by
- Russian Foundation for Basic Research. Grant Number: 02-04-07573
- Duke University, NC. Grant Number: 02-SC-NIH-1047
- Abstract
- Article
- References
- Cited By
Keywords:
- light-at-night;
- spontaneous tumors;
- life span;
- CBA mice
Abstract
The effect of constant illumination on the development of spontaneous tumors in female CBA mice was investigated. Fifty female CBA mice starting from the age of 2 months were kept under standard light/dark regimen (12 hr light:12hr dark; LD) and 50 CBA mice of similar age were kept under constant illumination (24 hr a day, 2,500 Lux, LL). Exposure to the LL regimen decreased food consumption but did not influence body weight, significantly accelerated age-related disturbances in estrous function, and was followed by a significant increase in spontaneous tumor incidence in female CBA mice. Tumor incidence as well as the number of total or malignant tumors was significantly increased in the LL group compared to the LD group (p < 0.001). The incidence of lung adenocarcinomas, leukemias and hepatocarcinomas was 7/50; 6/50 and 4/50 in the LL group and 1/50; 0/50 and 0/50 in the LD group. Mice from the LL groups had shorter life spans then those from the LD group. The data demonstrate, for the first time, that exposure to constant illumination was followed by increases in the incidence of spontaneous lung carcinoma, leukemias and hepatocarcinoma in female CBA mice. © 2004 Wiley-Liss, Inc.
Alternation of the day and night circadian cycle is an important regulator of a wide variety of physiological rhythms in organisms. Light exposure at night has been found to be related to a number of serious behavioral and health problems including cancer. In rodents, light-at-night leads to disruption of the ovulatory cycle followed by hyperplastic processes and tumor development in mammary gland, ovaries and uteri.1, 2 A tumor-promoting effect of exposure to the LL regimen was shown on chemical carcinogenesis in the mammary gland of rats.3, 4, 5, 6 Prolonged light exposure suppresses the night peak of melatonin, the ‘hormone of the night.’7, 8 Melatonin is the principal hormone of the pineal gland, the small neuroendocrine gland connected with the brain that mediates information on light from the retina to the organism.7, 8
A significant increase in the risk of breast and colorectal cancers was shown in women who frequently did not sleep during the period of the night, about 1:30 a.m., when melatonin levels are typically the highest.9, 10, 11, 12 The ‘Melatonin hypothesis’ suggests reduced pineal melatonin production might increase human breast cancer risk because lower melatonin output would lead to an increase in female sex hormones and stimulate proliferation of breast tissue.13 Data on the enhancing effect of constant illuminations on spontaneous endometrial carcinogenesis in BDII/Han rats14 agree with this suggestion. There are data on the promoting effect of the LL regimen on hepatocarcinogenesis induced by N-nitrosodimethylamine (DENA) in rats15 and on the development of neurogenic and kidney tumors in progeny of rats exposed to N-nitrosomethylurea in utero.16 We report, for the first time, that exposure to constant illumination increased the incidence of spontaneous lung carcinoma, leukemias and hepatocarcinoma in female CBA mice.
MATERIAL AND METHODS
Animals
One hundred 2-month-old female CBA mice were purchased from the “Rappolovo” Animal Farm of the Russian Academy of Medical Sciences. There are data on synthesis and secretion of melatonin by pineal gland of CBA mice.17 Mice were randomly subdivided into 2 groups and kept 5 per polypropylene cages (30 × 21 × 10 cm) under standard light/dark regimen (12 hr light:12 hr darkness; LD) or constant light regimen (LL) at a temperature of 22 ± 2°C and received standard laboratory chow18 and tap water ad lib.
Experimental design
In the LD regimen mice were exposed from 08:00–20:00 hr to electric lamps (75 W, 200 V, Russia) with the illumination of 300 Lux at the bottom of cages at a distance of 1.7 m. In the LL regimen mice were exposed to 2 luminescent lamps LB-40-2 (Russia) with illumination of 2,500 Lux at the bottom of cages at a distance of 1.5 m. It was shown earlier in our experiments that the constant exposure to 2,500 Lux more effective induced disturbances in estrus function and promoted spontaneous carcinogenesis in HER-2/neu mice as compared to the exposure to 300 Lux.19 Control of the illumination was carried out weekly with the luxmeter U-116 (GOST-14841, Russia). The weekly measure of air temperature at the level of the cages with animals failed to show any significant changes in the room temperature at the constant illumination conditions as compared to the room at the LD regimen. Once a week, all mice were palpated to detect mammary tumors. Once every 3 months, 5 times daily for 2 weeks, vaginal smears were cytologically examined to determine estrus function. Animals were kept under LD or LL regimens until their natural death.
Pathomorphological examination
All dead animals were autopsied. All tumors, as well as tissues and organs with suspected tumor development, were excised and fixed in 10% neutral formalin. After routine histological processing, tissues were embedded in paraffin; 5–7 μm thin histological sections were stained with haematoxylin and eosin and microscopically examined. Tumors were classified according to the International Agency for Research on Cancer recommendations.20
Statistics
Experimental results were analyzed using STATGRAPH. The significance of discrepancies was defined by the Student's t-criterion, Fischer's exact method, χ2 and non-parametric Wilcoxon-Mann-Whitney. Student-Newman-Keuls method was used for pairwise comparisons.21 For discrepancies in neoplasm incidence to be estimated, an IARC method of combined contingency tables calculated individually for the fatal and incidental tumors.22 For survival analysis, Cox's method23 was used for testing 2 groups. Taron's life table test24 was used. All test values reported for survival analyses are 2-sided.
Mathematical models and estimations
Survival is described using the Gompertz hazard with the survival function,
where α and β are parameters associated with age and the initial mortality rate, respectively. Parameters were estimated using the maximum likelihood method implemented in the Gauss statistical system.25
RESULTS
Daily observations have shown that, under constant illumination mice were more active, had increased locomotor activity, aggressiveness and depilation (baldness) compared to mice from the LD group. The cases of cataract never were registered in groups kept at the LD or LL regimens.
Food consumption of the LL group was significantly less (on average 30%) compared to LD groups from the 6–16 months of age (Table I). The body weight of mice in both groups increased with age but did not significantly differ (Table II). There were no significant differences in the length of estrous cycles between groups exposed to LD or LL regimen (Table III). At 6 months of age the relative number of days with estrus was increased in the LL group. In the LD group, the age-related decrease of the incidence of short estrous cycles (<5 days) and increase of long cycles (5–7 days) as well as increase in the rate of irregular estrous cycles was observed (Table III). Exposure to the LL regimen significantly accelerated age-related disturbances in estrous in CBA mice. At 6 months of age no mouse had short estrous cycles; 80% had irregular estrous cycles.
| Light/dark regimen | Daily food consumption (g/mouse) | ||||
|---|---|---|---|---|---|
| 3 months | 6 months | 8 months | 12 months | 16 months | |
| |||||
| LD | 2.6 ± 0.2 | 3.8 ± 0.3 | 3.9 ± 0.1 | 3.4 ± 0.4 | 3.5 ± 0.4 |
| LL | 3.1 ± 0.2 | 2.5 ± 0.31 | 2.7 ± 0.22 | 2.4 ± 0.13 | 2.4 ± 0.13 |
| Light/dark regimen | Body weight (g) | |||||
|---|---|---|---|---|---|---|
| 3 months | 6 months | 8 months | 11 months | 16 months | 19 months | |
| ||||||
| LD | 22.3 ± 0.21 | 25.9 ± 0.3 | 28.7 ± 0.5 | 29.5 ± 0.8 | 30.1 ± 0.8 | 30.2 ± 0.8 |
| LL | 22.2 ± 0.21 | 26.2 ± 0.5 | 28.9 ± 0.5 | 28.8 ± 0.7 | 29.0 ± 0.8 | 31.6 ± 1.1 |
| Age (months) | Mice (n) | Length of estrous cycle (days) | Rate of separate phases of estrous cycle (%) | Rate of estrous cycles (%) | Number of mice with regular cycles (%) | Number of mice with irregular cycles (%) | |||
|---|---|---|---|---|---|---|---|---|---|
| Estrus | Diestrus | <5 days | 5–7 days | > 7 days | |||||
| |||||||||
| LD regimen | |||||||||
| 3 | 29 | 6.0 ± 0.3 | 45.8 | 49.4 | 29.0 | 47.0 | 24.0 | 88.4 | 11.6 |
| 6 | 22 | 6.9 ± 0.4 | 34.0 | 64.7 | 27.0 | 37.0 | 36.0 | 85.0 | 15.0 |
| 9 | 18 | 7.2 ± 0.4 | 60.0 | 37.7 | 14.0 | 72.0 | 14.0 | 67.0 | 33.0 |
| 12 | 18 | 7.9 ± 0.6 | 52.0 | 46.0 | 11.0 | 67.0 | 22.0 | 43.0 | 57.0 |
| LL regimen | |||||||||
| 3 | 30 | 6.7 ± 0.5 | 46.7 | 52.8 | 24.0 | 40.0 | 36.0 | 67.61 | 32.41 |
| 6 | 30 | 9.2 ± 0.8 | 54.51 | 43.7 | 0 | 17.0 | 83.03 | 20.03 | 80.03 |
| 9 | 27 | 5.6 ± 0.4 | 50.0 | 50.0 | 0 | 100 | 0 | 7.2 | 92.8 |
| 12 | 26 | 6.7 ± 0.5 | 42.4 | 54.6 | 0 | 50.0 | 50.01 | 4.03 | 96.02 |
The mean life span of mice was similar in both groups, however the mean life span of last 10% survivors was reduced in the LL group (P < 0.001). The population aging rate estimated as α in the Gompertz equation was increased, and MRDT decreased, in the LL group in comparison to the LD group (P < 0.05) (Table IV, Fig. 2a).
| Parameters | Light/dark regimen | |
|---|---|---|
| LD | LL | |
| ||
| Number of mice | 50 | 50 |
| Mean life span, days (mean ± SE) | 665 ± 45.3 | 694 ± 34.3 |
| Median | 713 | 741 |
| Mean life span of last 10% of survivors | 1020 ± 4.5 | 965 ± 1.83 |
| Maximum life span | 1036 | 971 |
| α (days-1)1 | 3.42 (3.37–3.46) | 5.42 (5.36–5.47)4 |
| MRDT, days2 | 203 (200.2–205.5) | 128 (126.7–129.3)4 |

Figure 2. Effect of the exposure to the constant illumination (LL) on survival and tumorigenesis in female CBA mice. Abscissa, age, days. (a) Survival. Ordinate, number of mice, %. The difference in the survival of mice kept at the LD and the LL regimen was significant (p < 0.05) at the age of 900–1050 days. (b) Age-dependent tumor rate curves. Ordinate, number of tumor-bearing mice, %.
Exposure to constant illumination was followed by a significant increase in spontaneous tumor incidence in female CBA mice (Table V). The 1st tumor in the LL group (leukemia) was detected 10 months earlier than in the LD group. At autopsy enlargement of the spleen, liver, thymus and mesenterial lymph nodes was observed. Microscopically significant infiltration of the liver and some other organs with atypical lymphocytes was revealed (Fig. 1). Total tumor incidence as well as the total number of malignant tumors was significantly greater in the LL compared to the LD group (p < 0.001). Cumulative tumor yield curves for the LD and LL mice were significantly different (Fig. 2b). The incidence of lung adenocarcinomas, hepatocarcinomas and leukemias was higher in the LL group than the LD group. There were no significant differences in the incidence of other spontaneous tumors between LD and LL groups.
| Parameters | Light/dark regimen | |
|---|---|---|
| LD | LL | |
| ||
| Number of mice | 50 | 50 |
| The time of the 1st tumor detection, days | 610 | 312 |
| Mean life span of tumor-bearing animals, days | 700 ± 39.4 | 699 ± 48.9 |
| Tumor-bearing mice, n (%) | 4 (10) | 15 (35)1 |
| Total tumors, n | 5 | 22 |
| Malignant tumors, n | 3 | 19 |
| Tumor, incidence, localization and type | ||
| Lungs | ||
| Adenoma | 1 | 1 |
| Adenocarcinoma | 1 | 72 |
| Liver | ||
| Hemangioma | — | 1 |
| Hepatocellular carcinoma | — | 4 |
| Malingnant lymphoma/leukemia | — | 63 |
| Mammary gland, adenocarcinoma | 1 | 24 |
| Soft tissues, histiocytic fibrous sarcoma | 1 | — |
| Skin, basalioma | 1 | |
| Forestomach, papilloma | — | 1 |

Figure 1. Lympholeukemia in CBA mice exposed to constant light regimen. There is a significant lymphatic infiltration of liver (H&E, ×320).
Survival in mice exposed to the LD or the LL regimen is presented in Figure 2. Survival was similar in both groups. The curves crossed at age 27 months. At age 32 months survival was 2 times higher for mice from group LD than group LL (p < 0.05; Fischer exact test). The last mouse from the group LL died at age 971 days. At this age 30% of mice in the LD group were alive. The last died 2 months later.
DISCUSSION
In mammals, exposure to bright constant illumination alters the central circadian pacemaker activity of the suprachiasmatic nucleus in the hypothalamus. Constant light exposure or pinealectomy blocks the circadian melatonin signal emanating from the mammalian pineal gland every 24 hr.7, 8 When introduced during the dark phase, bright light inhibits melatonin production.7, 8
Artificially increasing the length of light phase of day (by 2–4 hr) was followed by increases in the duration of estrous cycle and in some cases to disturbances. If the light is on 24 hr/day the majority of female mice and rats in a short period showed a persistent estrus syndrome. In physiological circumstances, this syndrome naturally develops at some age (in rats, usually between 15th and 18th months) and precedes anestrus,26 being the physiological equivalent of climacteric syndrome and climacteric in women. The ovary of persistent-estrus rats contains follicular cysts, hyperplasia of theca-tissue, whereas corpora lutea are absent.1, 2, 26 Instead of cyclic production of gonadotropins, prolactin, estrogens and progesterone characteristic for the normal reproductive period of life, their production was acyclic with hyperplastic processes in mammary gland, ovaries and uterus.1, 2, 26, 27 Decrease in glucose tolerance and of sensitivity to insulin have been observed in rats with persistent-estrus.2 We have found that exposure to the LL regimen leads to increases in the threshold of sensitivity of the hypothalamus to feedback inhibition by estrogens in female rats.28 This is crucial in the aging of reproductive system in female rats as well as in women.28, 29, 30 Disturbances in estrous function developed earlier in CBA mice from the LL group.
Exposure to the LL regimen promoted spontaneous mammary carcinogenesis in female C3H and transgenic HER-2/neu FVB/N mice31, 32 and mammary carcinogenesis induced by 7,12-dimethylbenz(a)anthracene (DMBA) or N-nitrosomethylurea (NMU) in female rats.2, 3, 4, 5, 6, 33 Exposure to the LL regimen accelerated spontaneous uterine carcinogenesis in BDII rats.14 In our experiments constant light illumination promoted development of spontaneous hepatocarcinomas, lymphomas/leukemias and lung adenocarcinomas. Blask et al.33 reported that when male rats bearing tissue-isolated hepatoma 7288CTC and ER+ adenocarcinoma of the liver were exposed to constant bright light during the dark phase of 12L:12D photoperiod, the latency to onset was significantly reduced whereas the growth of tumors was markedly increased over a 4-week period as compared to control tumors in the LD group. There is evidence of the promoting effect of the LL regimen on DENA-induced hepatocarcinogenesis in rats.15 On the other hand, treatment with melatonin inhibited the growth of mouse hepatoma cell line HEPA 1-6,34 inhibited cellular proliferation, doubled mean life-time and increased survival of rats inoculated with hepatoma AH 13035 and inhibited induction of preneoplastic liver lesions in rats exposed to DENA.36 A low serum melatonin level was observed in hepatic porphyria patients with hepatocellular carcinoma.37
Spontaneous malignant tumors of liver, lung and hematopoietic tissues are common in male CBA mice,38 whereas lung adenomas, ovarian hemangiomas and low incidence of mammary carcinomas are typical for female CBA.38, 39 Disturbances in estrous function due to constant illumination can be a key factor in development of liver tumors in female CBA mice. An increased production of aromatized (nonclassic) phenol steroids was found in ovaries of rats exposed to the LL regimen.40, 41 The persistent estrus syndrome induced by orthotopic ovarian transplantation after ovariectomy or X-ray irradiation was characterized by similar changes in ovarian steroidogenesis and masculinization in female rats.26, 30
We failed to find any references to the effect of the LL regimen on hematopoietic tissue and lung tumor development. There is evidence of the oncostatic effect of melatonin on mammary tumor growth in vitro and in vivo experiments.2, 3, 4, 5, 6, 18, 33, 42 There are data on the inhibitory effect of melatonin on DMBA-induced cervico-vaginal carcinogenesis in mice43 and 1,2-dimethylhydrazine-induced colon carcinogenesis in rats.44, 45
Mechanisms of the inhibitory effect of melatonin on carcinogenesis include a variety of possibilities, discussed in several comprehensive reviews and include antioxidant and antiproliferative effects, increase in apoptosis and inhibitory effect on telomerase activity in tumor cells in vivo and in vitro, antiestrogenic effects, decreased IGF-1 and insulin levels, etc.2, 3, 46, 47, 48, 49
In conclusion, the data in our study demonstrates that exposure to light-at-night may have an important role in the development of not only mammary tumors but also a wide spectrum of tumors of different localization.
REFERENCES
- 1. Experimental bases of treatment of mastopathy with iodine microdoses. PhD Thesis. Moscow: All-Union Cancer Center, 1966.
- 2. The light-dark regimen and cancer development. Neuroendocrinol Lett 2002; 23 (Suppl): 28–36.
- 3, , , , . Light during darkness, melatonin suppression and cancer progression. Neuroendocrinol Lett 2002; 23 (Suppl): 52–6.
- 4, , . The relationship between electromagnetic field and light exposure to melatonin and breast cancer risk: a review of the relevant literature. J Pineal Res 1999; 26: 65–100.Direct Link:
- 5. Effect of hypothalamo-pituitary lesions induced by constant illumination on development of induced mammary tumors in rats. Vopr Exp Oncol (Kiev) 1965; 1: 87–93.
- 6, , , , . Light deprivation, electromagnetic fields and mammary carcinogenesis. Adv Pineal Res 1994; 7: 229–34.
- 7. Melatonin and the mammalian pineal gland. London: Chapman and Hall, 1995.
- 8. Pineal melatonin: cell biology of its synthesis and of its physiological interactions. Endocr Rev 1991; 12: 151–80.
- 9. Increased breast cancer risk among women who work predominantly at night. Ann Epidemiol 2001; 12: 74–7.
- 10, , . Night shift work, light at night, and risk of breast cancer. J Natl Cancer Inst 2001; 93: 1557–62.
- 11, , , , , , . Rotating night shifts and risk of breast cancer in women participating in the nurses' health study. J Natl Cancer Inst 2001; 93: 1563–8.
- 12, , , , , , , . Night-shifts work and risk of colorectal cancer in the nurses' health study. J Natl Cancer Inst 2003; 5: 825–8.
- 13, . Light in the built environment: potential role of circadian disruption in endocrine disruption and breast cancer. Cancer Causes Control 2001; 12: 279–87.
- 14, , , . Effect of melatonin and physiological epiphysectomy on the development of spontaneous endometrial carcinoma in BDII/Han rats. Cancer Biother Radiother 1997; 12: 420.
- 15, , , , , , The tumor promoting effect of constant light exposure on diethylnitrosamine-induced hepatocarcinogenesis in rats. Life Sci 1999; 64: 2523–34.
- 16, , , . Effect of light/dark regimen on N-nitrosomethylurea-induced transplacental carcinogenesis in rats. Cancer Lett 2001; 163: 51–7.
- 17, , , . Melatonin content of the pineal gland in different mouse strains. J Pineal Res 1989; 7: 195–204.Direct Link:
- 18, , , , , , , . The effect of melatonin treatment regimen on mammary adenocarcinoma development in HER-2/neu transgenic mice. Int J Cancer 2003; 103: 300–5.Direct Link:
- 19, , , , , , , , , . Light regimen, anovulation, and risk of malignant tumors of the female reproductive system: the mechanisms of link and prevention. J Obstet Woman Dis 2003; 52: 47–58.
- 20, , eds. Pathology of tumours in laboratory animals. vol. 1. Tumours of the mouse. 2nd ed. (IARC Sci. Publ. No 111). Lyon: IARC, 1994.
- 21. Computing methods of pathology analysis and recognition. Leningrad: Meditsina, 1978.
- 22, , , , . Statistical methods in cancer research. Vol. III— The design and analysis of long-term animal experiments. IARC Scientific Publication 79. IARC, Lyon: IARC, 1986.
- 23, . Analysis of survival data. London: Chapman and Hall, 1996.
- 24. Tests for trend in life table analysis. Biometrika 1975; 62: 679–82.
- 25Graphic Manual. Maple Valley: Aptech Systems, Inc., 1994.
- 26. Carcinogenesis and aging. Vol 2. Boca Raton: CRC Press, 1987.
- 27. Polycystic ovarian disease: animal models. Endocrinol Metab Clin North Am 1988; 17: 705–32.
- 28, . 1979. Hypothalamic mechanisms of ageing and of specific age pathology - I. Sensitivity threshold of hypothalamo-pituitary complex to homeostatic stimuli in the reproductive system. Exp Gerontol 1979; 14: 161–74.
- 29. Molecular and physiological mechanisms of aging. St. Petersburg: Nauka, 2003.
- 30. Gonadotropin secretion during aging in women: review article. Exp Gerontol 1996; 30: 369–81.
- 31. Trends in photophysiologic concepts. Ann NY Acad Sci 1964; 117: 88–104.Direct Link:
- 32, , , , , , , . Effect of light regimen and melatonin on the development of spontaneous mammary tumors in HER-2/neu transgenic mice is related to a downregulation of HER-2/neu gene expression. Neuroendocrinol Lett 2001; 22: 439–45.
- 33
- 34, , , . Potentiation of antiproliferative effects of tamoxifen and ethanol on mouse hepatoma cells by melatonin: possible involvement of mitogen-activated protein kinase and induction of apoptosis. J Pineal Res 2002; 33: 8–13.Direct Link:
- 35, , , . Melatonin's growth-inhibitory effect on hepatoma AH 130 in the rat. Cancer Lett 1998; 125: 51–9.
- 36, , , , , , , , . Inhibitory effect of low doses of melatonin on induction of preneoplastic liver lesions in a medium-term liver bioassay in F344 rats: relation to the influence of electromagnetic near field exposure. Cancer Lett 2000; 155: 105–14.
- 37, , , , , , . Hepatocellular carcinoma in patients with acute hepatic porphyria: frequency of occurrence and related factors. J Hepatol 2000; 32: 933–9.
- 38, , . Incidence and spectrum of spontaneous neoplasms in male and female CBA/J mice. Exp Toxicol Pathol 2000; 52: 221–5.
- 39, , , , , , , . Melatonin increases both life span and tumor incidence in female CBA mice. J Gerontol Biol Sci 2001; 56A: B311–23.
- 40, , . Influence of light and 9,10-dimethylbenz(a) anthracene on rat ovarian steroidogenesis: neutral steroids. Biochem J 1968; 110: 29p–30p.
- 41, , . Influence of light and 9,10-dimethylbenz(a)-anthracene on rat ovarian steroidogenesis: phenolic steroids. Biochem J 1968; 110: 28p–9p.
- 42, , , . Melatonin and mammary cancer: a short review. Endocr Relat Cancer 2003; 10: 153–9.
- 43, , , , , , , , . Inhibitory effect of melatonin on 7,12-dimethylbenz [a]anthracene-induced carcinogenesis of the uterine cervix and vagina in mice and mutagenesis in vitro. Cancer Lett 2000; 156: 199–205.
- 44, , . Melatonin and colon carcinogenesis: Inhibitory effects of melatonin on development of intestinal tumors induced by 1,2-dimethylhydrazine in rats. Carcinogenesis 1997; 18: 1549–53.
- 45. Melatonin and colon carcinogenesis. In: BartschC, BartschH, BlaskDE, CardinaliDP, HrusheskyWJM, MeckeD, eds. The pineal gland and cancer. Neuroimmunoendocrine mechanisms in malignancy. Berlin: Springer, 2001. 240–58.
- 46. An overview on the neuroendocrine regulation of experimental tumor growth by melatonin and its analogues and the therapeutic use of melatonin in oncology. In: BartschC, BartschH, BlaskDE, CardinaliDP, HrusheskyWJM, MeckeD, eds. The pineal gland and cancer. Neuroimmunoendocrine mechanisms in malignancy. Berlin: Springer, 2001. 309–42.
- 47. Reactive oxygen species, DNA damage, and carcinogenesis: intervention with melatonin. In: BartschC, BartschH, BlaskDE, CardinaliDP, HrusheskyWJM, MeckeD, eds. The pineal gland and cancer. Neuroimmunoendocrine mechanisms in malignancy. Berlin: Springer, 2001. 442–55.
- 48, , , , , . Melatonin and cell death: differential actions on an apoptosis in normal and cancer cells. Cell Mol Life Sci 2003; 60: 1407–26.
- 49, , , , . Melatonin inhibits telomerase activity in theMCF-7 tumor cell line both in vivo and in vitro. J Pineal Res 2003; 35: 204–11.Direct Link:

1097-0215/asset/olbannerleft.jpg?v=1&s=45719cd7de57873027993264fcc568b335a8cd56)
1097-0215/asset/olbannerright.jpg?v=1&s=5e0fba63c1309b3036eb9215a0e1e83dd02efd19)

